As a good method of treatment, Parkinson's disease patch is being developed for treating Parkinson's disease. This is being developed as a good method of treating it orally. The need to develop a skin patch for Parkinson's existed, due to the digestive tract of people affected by the disease.
Skin patches are available for smoking cessation, heart problems, and pain control. A major research is going on for exploring new ways of treatment except oral medicines, of Parkinson's. The silicon patch that is being used in the clinical trials have Dopamine agonist , a drug commonly used to reduce the symptoms and help people lead a more normal life. 'Neupro' is the first trans-dermal patch that has been approved to treat symptoms of Parkinson's disease.
DISEASE
The main symptoms of Parkinson's include memory loss, decrease of cognitive skills, dementia. As it is a disorder of the central nervous system, motor skills are lost over time. These Parkinson's disease patch medicines help in prolonging normal activity and suppressing the symptoms of the disease.
The main symptoms of this disease include stiffness and tremors in the limbs which is due to the reduction of Dopamine, chemical in the brain which controls movement in the body. Dopamine agonists clone dopamine and also stimulate the cells of the brain, just the way the normal chemical reacts.
Another Parkinsons disease patch that has been marketed is an active ingredient Rotigotine, which is a Dopamine receptor delivered through a skin patch. It is applied once to the skin and releases Ritigotine throughout 24 hours. Every day the patch needs to be changed. It is delivered to maintain stable rotigotine plasma in concentration level. The oral Dopamine agonists come in multiple doses but a patch is more effective and easy.
No comments:
Post a Comment